BSA Conjugated Human Thymosin Beta 4 (TMSB4X)

Produktübersicht

• Artikelname: BSA Conjugated Human Thymosin Beta 4 (TMSB4X)
• Artikelnummer: BIM-RPU50865
• Hersteller Artikelnummer: RPU50865
• Alternativnummer: BIM-RPU50865-50UG,BIM-RPU50865-100UG,BIM-RPU50865-1MG
• Hersteller: Biomatik Corporation
• Kategorie: Proteine/Peptide
• Applikation: SDS-PAGE, WB
• Spezies Reaktivität: Human
• Konjugation: BSA
• Alternative Synonym: Tb4, FX, PTMB4, TB4X, TMSB4, Thymosin,Beta 4,X-Linked, TB-500, Seraspenide, Hematopoietic system regulatory peptide

Produktbeschreibung

BSA Conjugated Human Thymosin Beta 4 (TMSB4X) is a purified Conjugated Small Molecules. Purity: >90% by SDS-PAGE. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Thymosin Beta 4 (TMSB4X). Target Synonyms: Tb4, FX, PTMB4, TB4X, TMSB4, Thymosin,Beta 4,X-Linked, TB-500, Seraspenide, Hematopoietic system regulatory peptide. Accession Number: P62328. Gene ID: 7114. Expression Region: Glu25~Ser44. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Produkteigenschaften

• Tag: N-Terminal His Tag
• NCBI: 7114
• Puffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
• Expression System: Protein Conjugation
• Reinheit: >90% by SDS-PAGE
• Formulierung: Freeze-dried powder
• Target-Kategorie: Thymosin Beta 4 (TMSB4X)